Alberto Valido, Luz E Robinson, Ashley B Woolweaver, Anne Drescher, Dorothy L Espelage, Ashlen A Wright, Dezja Ishmeal, Megan M Dailey, Anna C J Long, Scott LoMurray
Pilot Evaluation of the Elementary Social-Emotional Learning Program Sources of Strength
School mental health
burden cervical cancer ghana high due lack national screening vaccination program geographical variations highrisk human papilloma virus incidence type considered vaccine improvement screening lmics descriptive multicenter crosssectional study purposive sampling cases cervical cancer diagnosed january 2012 december 2018 employed relying archived formalin fixed paraffin embedded ffpe tissues four 4 teaching hospitals cervical cancers assessed histopathological features following guidelines addition novel tumour budding nest size grade tbns scc silva pattern invasion eac tumour infiltrating lymphocytes tils assessed high risk hpv testing performed using isothermal multiplex nucleic acid amplification method atila biosystem mountain view california usa ffpe blocks tested 15 hrhpv genotypes results analyzed using spss v260 descriptive statistics crosstabulation chisquare tests done significance established p 005 total 297 cases identified study ages ranging 20 95 years peak age group cervical cancer 46 55 years tested hrhpv positivity rate 854 eac 846 scc 856 top five hrhpv serotypes histological cancers 59 400 35 320 18 300 16 150 33 100 respectively approximately 582 infections multiple single hrhpv infections mostly caused hrhpv 59 289 16 263 tbns grade scc silva pattern invasion eac tils show statistically significant relationship hrhpv affirm reported differences hrhpv types associated cervical cancer ghana hrhpv types 59 35 33 forming significant proportion hrhpv types associated cervical cancer difference hrhpv types guide vaccine improvement triaging hrhpv positives though multiple infections common hrhpv types hrhpv 16 59 responsible single infections associated cervical cancer simple haematoxylin eosinbased morphological assessments improve prognostication patients cervical cancer